| Line Item | 2025-10-03 | Y/Y |
|---|---|---|
| Revenue | $844.6M | +4.1% |
| Cost of Revenue | $554.1M | +0.0% |
| Gross Profit | $290.5M | +13.1% |
| R&D Expense | $91.1M | +4.7% |
| SG&A Expense | $133.3M | -3.3% |
| Operating Income | -$27.8M | -186.6% |
| Pre-tax Income | -$59.2M | -1284.0% |
| Income Tax | $10.7M | -79.5% |
| Net Income | -$70.3M |
| Line Item | 2025-10-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.0M | -14.0% |
| Short-term Investments | $10.1M | -68.2% |
| Accounts Receivable | $156.6M | -0.7% |
| Inventory | $299.4M | +13.1% |
| Current Assets | $641.8M | -1.2% |
| Total Assets | $1.11B | -9.0% |
| Current Liabilities | $187.2M | -4.4% |
| Line Item | 2025-10-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $41.7M | -11.8% |
| Capital Expenditures | $22.9M | -14.9% |
| Investing Cash Flow | $10.3M | +137.5% |
| Financing Cash Flow | -$75.9M | -2200.0% |
| Free Cash Flow | $18.8M | -7.8% |
| -47.4% |
| EPS (Basic) | -$1.70 | -45.3% |
| EPS (Diluted) | -$1.70 | -45.3% |
| Long-term Debt |
| $367.5M |
| -17.1% |
| Total Liabilities | $620.8M | -7.0% |
| Stockholders' Equity | $472.6M | -11.7% |